Mark Genovese

Back to Profile

Publication Details

  • A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands.

    Magnano MD, Chakravarty EF, Broudy C, Chung L, Kelman A, Hillygus J, Genovese MC. J Rheumatol. 2007; 34 (6): 1323-7

    To determine if anti-tumor necrosis factor (TNF) therapy (adalimumab) can safely improve symptoms of erosive/inflammatory osteoarthritis (EOA).

    PubMedID: 17516620

Stanford Medicine Resources:

Footer Links: